Logo image of BYRN

BYRNA TECHNOLOGIES INC (BYRN) Stock Fundamental Analysis

NASDAQ:BYRN - Nasdaq - US12448X2018 - Common Stock - Currency: USD

29.175  -2.93 (-9.11%)

After market: 29.377 +0.2 (+0.69%)

Fundamental Rating

5

BYRN gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 65 industry peers in the Aerospace & Defense industry. BYRN is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. BYRN is valued quite expensively, but it does show have an excellent growth rating. With these ratings, BYRN could be worth investigating further for growth investing!.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

BYRN had positive earnings in the past year.
In the past year BYRN had a positive cash flow from operations.
BYRN had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: BYRN reported negative operating cash flow in multiple years.
BYRN Yearly Net Income VS EBIT VS OCF VS FCFBYRN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M -10M -15M

1.2 Ratios

The Return On Assets of BYRN (17.78%) is better than 96.88% of its industry peers.
With an excellent Return On Equity value of 23.53%, BYRN belongs to the best of the industry, outperforming 90.63% of the companies in the same industry.
The Return On Invested Capital of BYRN (9.33%) is better than 75.00% of its industry peers.
Industry RankSector Rank
ROA 17.78%
ROE 23.53%
ROIC 9.33%
ROA(3y)-3.9%
ROA(5y)-15.32%
ROE(3y)-4.33%
ROE(5y)-33.75%
ROIC(3y)N/A
ROIC(5y)N/A
BYRN Yearly ROA, ROE, ROICBYRN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K -1K 2K

1.3 Margins

With an excellent Profit Margin value of 14.92%, BYRN belongs to the best of the industry, outperforming 89.06% of the companies in the same industry.
With a Operating Margin value of 7.78%, BYRN perfoms like the industry average, outperforming 54.69% of the companies in the same industry.
BYRN has a better Gross Margin (61.54%) than 95.31% of its industry peers.
In the last couple of years the Gross Margin of BYRN has grown nicely.
Industry RankSector Rank
OM 7.78%
PM (TTM) 14.92%
GM 61.54%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.26%
GM growth 5Y30.43%
BYRN Yearly Profit, Operating, Gross MarginsBYRN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K

8

2. Health

2.1 Basic Checks

BYRN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for BYRN has been increased compared to 1 year ago.
Compared to 5 years ago, BYRN has more shares outstanding
There is no outstanding debt for BYRN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
BYRN Yearly Shares OutstandingBYRN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
BYRN Yearly Total Debt VS Total AssetsBYRN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

An Altman-Z score of 23.57 indicates that BYRN is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 23.57, BYRN belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
BYRN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 23.57
ROIC/WACC1
WACC9.37%
BYRN Yearly LT Debt VS Equity VS FCFBYRN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

A Current Ratio of 3.30 indicates that BYRN has no problem at all paying its short term obligations.
With a decent Current ratio value of 3.30, BYRN is doing good in the industry, outperforming 79.69% of the companies in the same industry.
BYRN has a Quick Ratio of 2.01. This indicates that BYRN is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of BYRN (2.01) is better than 75.00% of its industry peers.
Industry RankSector Rank
Current Ratio 3.3
Quick Ratio 2.01
BYRN Yearly Current Assets VS Current LiabilitesBYRN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

7

3. Growth

3.1 Past

BYRN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 663.64%, which is quite impressive.
BYRN shows a strong growth in Revenue. In the last year, the Revenue has grown by 101.07%.
The Revenue has been growing by 147.68% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)663.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%4200%
Revenue 1Y (TTM)101.07%
Revenue growth 3Y26.7%
Revenue growth 5Y147.68%
Sales Q2Q%78.89%

3.2 Future

Based on estimates for the next years, BYRN will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.58% on average per year.
Based on estimates for the next years, BYRN will show a quite strong growth in Revenue. The Revenue will grow by 18.79% on average per year.
EPS Next Y-22.51%
EPS Next 2Y10.58%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year29.23%
Revenue Next 2Y25.48%
Revenue Next 3Y28.89%
Revenue Next 5Y18.79%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
BYRN Yearly Revenue VS EstimatesBYRN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 50M 100M 150M 200M
BYRN Yearly EPS VS EstimatesBYRN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 0.5 -0.5

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 47.06, BYRN can be considered very expensive at the moment.
The rest of the industry has a similar Price/Earnings ratio as BYRN.
The average S&P500 Price/Earnings ratio is at 30.30. BYRN is valued rather expensively when compared to this.
A Price/Forward Earnings ratio of 60.73 indicates a quite expensive valuation of BYRN.
BYRN's Price/Forward Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.06, BYRN is valued quite expensively.
Industry RankSector Rank
PE 47.06
Fwd PE 60.73
BYRN Price Earnings VS Forward Price EarningsBYRN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

BYRN's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. BYRN is more expensive than 65.63% of the companies in the same industry.
BYRN's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 70.36
EV/EBITDA 76.73
BYRN Per share dataBYRN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y10.58%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for BYRN!.
Industry RankSector Rank
Dividend Yield N/A

BYRNA TECHNOLOGIES INC

NASDAQ:BYRN (2/20/2025, 8:02:28 PM)

After market: 29.377 +0.2 (+0.69%)

29.175

-2.93 (-9.11%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)02-07 2025-02-07/bmo
Earnings (Next)04-03 2025-04-03/bmo
Inst Owners40.13%
Inst Owner Change28.52%
Ins Owners19.4%
Ins Owner Change0.62%
Market Cap660.81M
Analysts84
Price Target26.14 (-10.4%)
Short Float %13.62%
Short Ratio4.38
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)150.86%
Min EPS beat(2)47.04%
Max EPS beat(2)254.68%
EPS beat(4)4
Avg EPS beat(4)181.66%
Min EPS beat(4)47.04%
Max EPS beat(4)254.68%
EPS beat(8)6
Avg EPS beat(8)-8.84%
EPS beat(12)7
Avg EPS beat(12)-21.73%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.87%
Min Revenue beat(2)-2.03%
Max Revenue beat(2)-1.7%
Revenue beat(4)2
Avg Revenue beat(4)10.9%
Min Revenue beat(4)-2.03%
Max Revenue beat(4)42.11%
Revenue beat(8)3
Avg Revenue beat(8)0.08%
Revenue beat(12)3
Avg Revenue beat(12)-2.23%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)12.95%
EPS NQ rev (1m)100%
EPS NQ rev (3m)-81.82%
EPS NY rev (1m)2.17%
EPS NY rev (3m)35.86%
Revenue NQ rev (1m)6.13%
Revenue NQ rev (3m)0.36%
Revenue NY rev (1m)0%
Revenue NY rev (3m)3.58%
Valuation
Industry RankSector Rank
PE 47.06
Fwd PE 60.73
P/S 7.71
P/FCF 70.36
P/OCF 56.29
P/B 12.15
P/tB 13.55
EV/EBITDA 76.73
EPS(TTM)0.62
EY2.13%
EPS(NY)0.48
Fwd EY1.65%
FCF(TTM)0.41
FCFY1.42%
OCF(TTM)0.52
OCFY1.78%
SpS3.79
BVpS2.4
TBVpS2.15
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 17.78%
ROE 23.53%
ROCE 11.81%
ROIC 9.33%
ROICexc 17.14%
ROICexgc 20.95%
OM 7.78%
PM (TTM) 14.92%
GM 61.54%
FCFM 10.95%
ROA(3y)-3.9%
ROA(5y)-15.32%
ROE(3y)-4.33%
ROE(5y)-33.75%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.26%
GM growth 5Y30.43%
F-Score7
Asset Turnover1.19
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 157.41%
Cap/Sales 2.74%
Interest Coverage 250
Cash Conversion 143.84%
Profit Quality 73.43%
Current Ratio 3.3
Quick Ratio 2.01
Altman-Z 23.57
F-Score7
WACC9.37%
ROIC/WACC1
Cap/Depr(3y)202.29%
Cap/Depr(5y)309.93%
Cap/Sales(3y)3.87%
Cap/Sales(5y)4.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)663.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%4200%
EPS Next Y-22.51%
EPS Next 2Y10.58%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)101.07%
Revenue growth 3Y26.7%
Revenue growth 5Y147.68%
Sales Q2Q%78.89%
Revenue Next Year29.23%
Revenue Next 2Y25.48%
Revenue Next 3Y28.89%
Revenue Next 5Y18.79%
EBIT growth 1Y185.62%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year187.86%
EBIT Next 3Y80.11%
EBIT Next 5Y53.44%
FCF growth 1Y214.22%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y201.62%
OCF growth 3YN/A
OCF growth 5YN/A